October 5, 2020
“Kala Pharmaceuticals (KALA)… In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%… Revance Therapeutics (RVNC)…… Continue Reading…
September 17, 2020
“Aquestive Therapeutics (AQST)… All in all, other analysts echo Moussatos’ sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $18.67, the upside potential comes in at 136%…… Continue Reading…
Recent Comments